Lawrenceville, NJ, October 9, 2023 (Yahoo Finance) -- Bristol-Myers Squibb (BMY) has announced its acquisition of cancer drug manufacturer Mirati Therapeutics (MRTX) for a potential sum of $5.8 billion. This strategic move will expand Bristol-Myers Squibb's cancer drug portfolio.
Read full article here.
Durham, NCÂ and Seattle, WA, January 12, 2025 (Business Wire) -- Tune Therapeutics has raised $175 million in Series B funding to...
Ribometrix Names William S. Marshall, Ph.D., as CEO to Drive Breakthrough RNA-Targeting Therapeutics
Durham, NC, January 09, 2025 (Globe newswire) -- Ribometrix has appointed Dr. William S. Marshall as CEO and Dr. Katie Warner as CSO,...
San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure...
Opmerkingen